Advertisement

Topics

Human medicines European public assessment report (EPAR): Zynquista, sotagliflozin, Diabetes Mellitus, Type 1, Date of authorisation: 26/04/2019, Status: Authorised

12:15 EDT 16 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zynquista, sotagliflozin, Diabetes Mellitus, Type 1, Date of authorisation: 26/04/2019, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zynquista, sotagliflozin, Diabetes Mellitus, Type 1, Date of authorisation: 26/04/2019, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zynquista, sotagliflozin, Diabetes Mellitus, Type 1, Date of authorisation: 26/04/2019, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...